Comment
|
EGF treatment induces both Akt and Erk phosphorylation in synaptosomes.
|
Formal Description Interaction-ID: 5213
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
EGF
or
AKT1
|
Drugbank
DB00364
|
|
Drugbank
DB04454
|
|
Drugbank
DB04454
|
|
Drugbank
DB00171
|
|
Drugbank
DB01169
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB00171
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
|
|
Comment
|
EGF treatment induces both Akt and Erk phosphorylation in synaptosomes.
|
Formal Description Interaction-ID: 5214
|
increases_phosphorylation of
|
Drugbank entries
|
Show/Hide entries for
EGF
or
MAPK1
|
Drugbank
DB00364
|
|
Drugbank
DB04454
|
|
Drugbank
DB04454
|
|
Drugbank
DB01064
|
|
Drugbank
DB01169
|
|
Drugbank
DB02116
|
|
Drugbank
DB02482
|
|
Drugbank
DB02733
|
|
Drugbank
DB04338
|
|
Drugbank
DB06877
|
N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL ...
|
Drugbank
DB07010
|
N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZO ...
|
Drugbank
DB07264
|
(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYD ...
|
Drugbank
DB07788
|
(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-M ...
|
Drugbank
DB07794
|
5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)- ...
|
Drugbank
DB07905
|
(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy ...
|
Drugbank
DB08513
|
[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENY ...
|
Drugbank
DB08521
|
4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFI ...
|
Drugbank
DB02482
|
|
Drugbank
DB02733
|
|
|
|
Comment
|
Akt-, but not Erk-signalling is significantly decreased in parkin knockout compared with wild-type synaptosomes.
|
Formal Description Interaction-ID: 5221
|
NOT increases_phosphorylation of
in synaptosomes
|
Drugbank entries
|
Show/Hide entries for
MAPK1
|
Drugbank
DB01064
|
|
Drugbank
DB01169
|
|
Drugbank
DB02116
|
|
Drugbank
DB02482
|
|
Drugbank
DB02733
|
|
Drugbank
DB04338
|
|
Drugbank
DB06877
|
N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL ...
|
Drugbank
DB07010
|
N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZO ...
|
Drugbank
DB07264
|
(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYD ...
|
Drugbank
DB07788
|
(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-M ...
|
Drugbank
DB07794
|
5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)- ...
|
Drugbank
DB07905
|
(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy ...
|
Drugbank
DB08513
|
[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENY ...
|
Drugbank
DB08521
|
4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFI ...
|
Drugbank
DB02482
|
|
Drugbank
DB02733
|
|
|
|
Comment
|
Akt-, but not Erk-signalling is significantly decreased in parkin knockout compared with wild-type synaptosomes.
|
Formal Description Interaction-ID: 5224
|
NOT increases_phosphorylation of
in synaptosomes
|
Drugbank entries
|
Show/Hide entries for
AKT1
|
Drugbank
DB00171
|
|
Drugbank
DB01169
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB00171
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
|
|